The average number of vaccine shots given each day, which rose for months and peaked at 3.38 million, has now fallen to 2.86 million, the lowest level since March 31.
Tag: Johnson & Johnson
Johnson & Johnson Vaccinations to Resume in South Africa
After a difficult 10 days, another piece of good news for the maker of a single-shot Covid-19 vaccine.
F.D.A. Cites Failures at Plant Where J.&J. Doses Ruined
The Food and Drug Administration issued highly critical findings from an inspection of the plant that was forced to throw out up to 15 million doses of Johnson & Johnson’s coronavirus vaccine and ordered to temporarily stop all production.
Johnson & Johnson to Resume European Union Vaccine Rollout
With the Johnson & Johnson vaccine paused in the United States, the European Union drug regulator found that the benefits outweigh the rare risk of blood clots.
J.&J. to Resume Its Covid Vaccine Rollout in Europe
The agency says the Johnson & Johnson coronavirus vaccine should have a warning for a potential risk for rare blood clots even though it believes the shot’s benefits outweigh risks. The agency did not recommend stopping use of the vaccine.
Handful of Unconfirmed Reports Are Being Examined After J.&J. Pause
Officials are trying to determine whether the reports might be cases of a rare, serious blood clotting disorder. It’s unclear whether the vaccine was responsible for the original cases.
Emergent BioSolutions halts operations at its Baltimore plant, where J.&J. doses were ruined, at the F.D.A.’s request.
The Times had reported that production of new batches of the Johnson & Johnson vaccine would be put on hold while the review was underway.
Fauci Expects Decision on Using Johnson & Johnson Vaccine Friday
Dr. Anthony Fauci said that he expected experts meeting at the end of the week to recommend “some sort of either warning or restriction.”
‘We Were Flying Blind’: A Dr.’s Account of a Woman’s J.&J. Vaccine-Related Blood Clot Case
The disorder is rare, but so severe that the vaccine is on hold while experts weigh the risks and alert doctors and patients about symptoms and treatment.
C.D.C. Panel to Meet Next Friday on J.&J. Vaccine Pause
The advisory panel will discuss safety data related to a small number of blood-clotting cases in Johnson & Johnson vaccine recipients. It is unclear whether the vaccine was responsible for the clots.